LAMAs Are Safe Irrespective of Cardiovascular Risk in COPD - Medscape

Medscape
LAMAs Are Safe Irrespective of Cardiovascular Risk in COPD
Medscape
SAN ANTONIO — Long-acting antimuscarinic antagonists (LAMAs) do not increase the risk for cardiovascular events in patients with moderate to very severe chronic obstructive pulmonary disease (COPD), a post hoc analysis of the ASCENT study ...